Abstract
Recently, public concerns have been expressed regarding the non-consented storage and secondary research uses of residual newborn bloodspot (RBS) samples. The purpose of this paper is to examine public responses to the storage and secondary uses of RBS that can be identified through analysis of media, legal cases, and documented public engagement activities. Coverage in the examined print media confirmed the importance of RBS to journalists and those people who expressed their concerns to these journalists. Several lawsuits, brought by parents concerned about the storage of newborn bloodspots, placed the practice of storing NBS into the spotlight. This resulted in controversial debates and the mandatory destruction of millions of samples. Analysis of public engagement activities across several jurisdictions indicated that across (inter)national boundaries there are common elements to what is perceived as inappropriate governance of RBS. Public concerns were grouped into five main themes: trust, transparency, confidentiality, ownership, and stigmatization/discrimination. The results of our analysis help to make a compelling case for placing citizens at the center of the debate and developing policy about the storage and secondary uses of newborn bloodspots.
Similar content being viewed by others
Notes
This study was limited to English-speaking jurisdictions. We would like to acknowledge the suggestion of a reviewer to compare our findings from analysis of this issue in English-speaking media, legal cases, and documented public engagement activities to those available in other common languages (e.g., French, Spanish). Although this research would be a valuable addition to the literature on the topic, it is outside the scope of this paper. Consequently, our analysis is limited in this regard and our analytical claims extend only to English language jurisdictions. However, a comparison of perceptions on this topic across different language jurisdiction is a possible avenue of future empirical study.
References
Armstrong J (2010) Storage of samples makes some parents’ blood boil. The globe and mail, pS1
Avard D, Vallance H, Greenberg C, Laberge C, Kharaboyan L, Plant M (2006) Variability in the storage and use of newborn dried bloodspots in Canada: is it time for national standards? Genomics Soc Policy 2(3):80–95
Bearder v. Minnesota, Order Granting Motion to Dismiss: No.27-CV-09-5615 (D.Minn.2009). Available at http://www.cchconline.org/pdf/JudgeRosenbaumOrder113009.pdf. Accessed September 2014
Beleno v. Tex. Dep’t of State Health Servs:No. 5:09-cv-00188-FB (W.D.Tex., San Antonio Division filed Mar. 12, 2009)
Benkendorf J, Goodspeed T, Watson MS (2010) Newborn screening residual dried blood spot use for newborn screening quality improvement. Genetics Med 12(Suppl 12):S269–S272
Bombard Y, Miller FA, Hayeems RZ, Carroll JC, Avard D, Wilson BJ et al (2012) Citizens’ values regarding research to store samples from newborn screening in Canada. Pediatrics 29:239–248
Botkin JR, Rothwell E, Anderson R, Stark L, Goldenberg A, Lewis M et al (2012) Public attitudes regarding the use of residual newborn screening specimens for research. Pediatrics 129(2):231–238
Botkin JR, Goldenberg AJ, Rothwell E, Anderson RA, Lewis MH (2013) Retention and research use of residual newborn screening bloodspots. Pediatrics 131:120–127
Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3:77–101
Burgard P, Cornel M, Di Filippo F, Haege G, Hoffmann GF, Lindner M, et al. (2012) Report on the practices of newborn screening for rare disorders implemented in Member States of the European Union, Candidate, Potential Candidate and EFTA countries. Available at http://ec.europa.eu/eahc/documents/news/Report_NBS_Current_Practices_20120108_FINAL.pdf. Accessed September 2014
Carmichael M (2011) A spot of trouble. Nature 475:156–159
Carnahan SJ (2011) Biobanking newborn bloodspots for genetic research without consent. Journal of Health Care Law and Policy
Centers for Disease Control and Prevention (2008) Newborn screening laboratory bulletin. Available at http://www.cdc.gov/nbslabbulletin/bulletin.html. Accessed September 2014
Chrysler D, McGee H, Bach J, Goldman E, Jacobson PD (2011) The Michigan BioTrust for health: using dried bloodspots for research to benefit the community while respecting the individual. J Law Med & Ethics Spring 2011:98–101
Cohen E (2010) The government has your baby’s DNA. CNN Health. Available at http://www.cnn.com/2010/HEALTH/02/04/baby.dna.government/ Accessed September 2014
Collin L (2011) Minnesota court backs families in handling of newborn blood. CBS Minnesota. http://minnesota.cbslocal.com/2011/11/16/court-backs-families-in-handling-of-newborn-blood. Accessed September 2014
Cornel M, Rigter T, Weinreich S, Burgard P, Hoffman GF, Lindner M et al (2012) Newborn screening in Europe: expert opinion document., Available at http://www.orpha.net/national/data/GR-EL/www/uploads/NBS_expert_opinion_final–1-.pdf. Accessed September 2014
Davey A, French D, Dawkins H, O’Leary P (2005) New mothers’ awareness of newborn screening, and their attitudes to the retention and use of screening samples for research purposes. Genomics Soc Policy 1(3):41–51
deBonnaire C, Autagavaia M, Simpson-Edwards M, Sutton C, Taylor T (2007) Newborn blood spot cards: consent, storage and use—a public consultation focus groups. Available at www.nsu.govt.nz/files/ANNB/NMSP_Focus_Groups_Final_Report.pdf. Accessed April 17, 2014.
Drabiak-Syed K (2010) Newborn blood spot banking: approaches to consent. Indiana University Center for Bioethics: Predict ER Law and Policy Update. Available at http://bioethics.iu.edu/programs/other/predicter/legal-updates/newborn-blood-spot-banking/ Accessed September 2014
Drabiak-Syed K (2011) Legal and regulation of banking newborn blood spots for research: how Bearder NS Belano resolved the question of consent. Hous J Health L & Pol’y 1–46
Driver C (2010) DNA from millions of newborn babies is secretly stored on NHS database. London Mail Online. Available at http://www.dailymail.co.uk/news/article-1280891/NHS-creates-secret-database-babies-blood-samples-parental-consent.html. Accessed September 2014
Duquette D, Rafferty AP, Fussman C, Gehring J, Meyer S, Bach J (2010) Public support for the use of newborn screening dried blood spots in health research. Public Health Genomics 14:143–152
Duquette D, Langbo C, Bach J, Kleyn M (2012) Michigan BioTrust for health: public support for using residual dried blood spot samples for health research. Public Health Genomics 15(3–4):146–155
Fleck LM, Mongoven A, Marzec S (2008) Informing the debate: stored blood spots—ethical and policy challenges. Report prepared for Michigan State University Institute for Public Policy and Social Research. Available at http://www.ippsr.msu.edu/Publications/ HPFleck.pdf. Accessed December 2012
Fujii C, Sato Y, Harada S, Kakee N, Gu YH, Kato T et al (2010) Attitude to extended use and long term storage of newborn screening bloodspots in Japan. Pediatr Int 52:393–397
Gehring J, Rafferty AP, Fussman C, Duquette D, Bach J (2009) Public opinion regarding the use of newborn screening dried blood spots: results from the 2008 MiBRFS. Michigan BRFSS Surveillance Brief 3(2):1–2
Godard B, Schmidtke J, Cassiman J, Aymé S (2003) Data storage and DNA banking for biomedical research: informed consent, confidentiality, quality issues, ownership, return of benefits. A professional perspectives. Eur J Hum Genet 11(Suppl 2):S88–S122
Gong L, Tu W, He J, Shi X, Wang X, Li Y (2012) The use of newborn screening dried blood spots for research: the parental perspective. Bioeth Inq 9:189–193
Government of Michigan Department of Community Health (2010) Michigan BioTrust for health: Frequently asked questions. Available at http://www.michigan.gov/mdch/0,1607,7-132-2942_4911_4916_53246-232933--,00.html. Accessed September 2014
Haak PT, Busik JV, Kort EJ, Paneth N, Tikhonenko M, Resau JH (2009) Archived unfrozen neonatal blood spots are amenable to quantitative gene expression analysis. Neonatology 95:210–216
Higgins v. Tex. Dep’t of State Health Servs: 801 F. Supp.2d 541 (Austin District Court, TX.2010)
Hollegaard MV, Grauholm J, Norgaard-Pedersen B, Hougaard DM (2013) DNA methylome profiling using neonatal dried blood spot samples: a proof-of-principle study. Mol Genet Metab 108(4):225–231
Institute of Medicine of the National Academies (2010) Challenges and opportunities in using residual newborn screening samples for translational research. Institute of Medicine
Kardia SLR (2011) The public’s perceptions related to uses of newborn screening dried blood spots. Available at http://www.acmg.net/StaticContent/Blood_Spot_Webinar/ Sharon_Kardia.pdf. Accessed December 2012
Kharaboyan L, Avard D, Knoppers BM (2004) Storing newborn blood spots: modern controversies. J Law Med & Ethics 32(4):741–748
Khoo SK, Vadlapatla NM, Dykema K et al (2011) Acquiring genome-wide gene expression profiles in Guthrie card blood spots using microarrays. PatholInt 61:1–6
Kilakkathi V (2012) Newborn screening in America: problems and policies. Council for Responsible Genetics. Available at http://www.councilforresponsiblegenetics.org/pageDocuments/WNMAKEPP1P.pdf. Accessed September 2014
Knoppers BM, Avard D, Sénécal K (2012) Newborn screening programmes: emerging biobanks? NorskEpi 21(2):163–168
Laberge C, Kharaboyan L, Avard D (2004) Newborn screening, banking, and consent. GenEdit 2(3):1–15
Langbo C, Bach J, Kleyn M, Downes FP (2013) From newborn screening to population health research: implementation of the Michigan BioTrust for health. Public Health Rep 128(5):377–384
LD v. Provincial Health Services Authority of British Columbia: 2011 BCJ 899; 2012 BCCA 491
LeRoy L, Robbins R, Shier V, Katz LY, Doksum T (2005) Summary of living room forums on genetics. Report prepared for the Washington Department of Health Genetic Services Section
Lewis MH, Goldenberg A, Anderson R, Rothwell E, Botkin J (2012) State laws regarding the retention and use of residual newborn screening blood samples. Pediatrics 127:703–712
Maschke KJ (2009) Disputes over research with residual newborn screening blood specimens. Bioethics Forum. Available at http://www.thehastingscenter.org/Bioethicsforum/Post.aspx?id=3826. Accessed September 2014
McLoughlin D (2005) Written in blood. New Zealand Dominion Post
Minnesota Genetic Information Work Group (2009) Genetic information in Minnesota: a report to the Minnesota State Legislature. Available at http://www.ipad.state.mn.us/docs/genrpt09.pdf. Accessed September 2014
Muchamore I, Morphett L, Barlow-Stewart K (2006) Exploring existing and deliberative community perspectives of newborn screening: informing the development of state and national policy standards in newborn screening and the use of dried blood spots. Aust N Z Health Policy 3(1):14–22, Available at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1712344/ Accessed September 2014
Neidich AB, Joseph JW, Ober C, Ross LF (2008) Empirical data about women’s attitudes towards hypothetical pediatric biobank. Am J Med Genet; Part A(146A): 297–304
Newborn Metabolic Screening Programme Advisory Group (2008) Recommendations to the National Screening Unit for the retention period and secondary use of Guthrie (‘blood spot’) cards. Available at http://www.nsu.govt.nz/files/ ANNB/NMSP_Advisory_Group_Report_July_2008.pdf. Accessed September 2014
Nickel K (2004) Screened for success? Kitsap Sun; p. B03
Norgaard-Pedersen B, Hougaard DM (2007) The Danish newborn screening biobank in practice and research: revised biobank regulations; in Knoppers BM (ed):Genomics and public health. The Netherlands, Martinus Nijhoff Publishers, pp. 97–110
Oklahoma State Senate (2010) Unauthorized storage and use of DNA from newborn without parental consent; S 1250. 52nd Legislature. 2nd Regular Session
Olson S, Berger AC (2010) Challenges and opportunities in using residual newborn screening samples for translational research: workshop summary., Available at http://www.nap.edu/catalog.php?record_id=12981. Accessed September 2014
Oregon Health Authority (2011) 2011 Report to the Oregon Legislature: advisory committee on genetic privacy and research. Available at http://public.health.oregon.gov/ diseasesconditions/geneticconditions/documents/acgpr2011legreport.pdf. Accessed September 2014
Padilla CD, Therrell BL (2012) Consolidating newborn screening efforts in the Asia Pacific region. J Community Genet 3:35–45
Provincial Health Services Authority (British Columbia-Canada) (2010) Storage, use, retention and disposal of newborn screening blood spot cards: policy and procedure
Ramshaw E (2010) DSHS turned over hundreds of DNA samples to Feds. The Texas Tribune. Available at http://www.texastribune.org/texas-state-agencies/department-of-state-health-services/dshs-turned-over-hundreds-of-dna-samples-to-feds/ Accessed July 2013
Richer J, Ghebremichael MS, Chudley AE, Robinson WM, Wilfond BS, Solomon MZ (2011) Research use of leftover newborn bloodspots: attitudes of Canadian geneticists regarding storage and informed consent requirements. Genet Med 13(4):305–313
Roser M (2009) Texans unknowingly donate children’s blood to research. Statesman, American
Rothwell E, Anderson R, Botkin J (2010) Policy issues and stakeholder concerns regarding the storage and use of residual newborn dried blood sample for research. Pol Polit Nurs Pract 11(1):5–12
Rothwell E, Anderson RA, Burbank MJ, Goldenberg AJ, Lewis MH, Stark LA et al (2011) Concerns of newborn blood screening advisory committee members regarding storage and use of residual newborn screening blood spots. Am J Public Health 101(11):2111–2116
Rothwell E, Anderson R, Goldenberg A, Lewis MH, Stark L, Burbank M et al (2012) Assessing public attitudes on the retention and use of residual newborn screening blood samples: a focus group study. SocSci Med 74:1305–1309
Rothwell E, Clark L, Anderson R, Botkin JR (2013) Residual newborn screening samples for research: parental information needs for decision-making. J Specialists Pediatr Nurs 18:115–122
Rowe G, Frewer LJ (2005) A typology of public engagement mechanisms. Sci Technol Hum Values 30:251–290
Royal College of Physicians of Ireland (2013) Newborn screening blood spot cards. Available at http://www.rcpi.ie/content/docs/000001/1619_5_media.pdf?1392207018. Accessed September 2014
Sénécal K, Stanton-Jean M, Avard D (2013) Promoting public involvement to increase the legitimacy in health policy decisions. J Int de Bioéthiqueetd’éthique des Sci 24(4):1–16
Stein R (2009) Newborns’ blood samples are used for research without parents’ consent. Washington Post. Available at http://www.washingtonpost.com/wp-dyn/content/article/2009/06/29/AR2009062903118.html. Accessed September 2014
Suter SM (2014) Did you give the government your baby’s DNA? Rethinking consent in newborn screening. Minn JL Sci & Tech 15(2):729–790
Swedish Ministry of Health and Social Affairs (2010) Report: a new biobank act (SOU 2010: 81)
Tarini BA (2011) Storage and use of residual newborn screening blood spots: a public policy emergency. Genet Med 13(7):619–620
Tarini BA, Goldenberg A, Singer D, Clark SJ, Butchart A, Davis MM (2009) Not without my permission: parents’ willingness to permit use of newborn screening samples for research. Public Health Genomics 13(3):125–130
Texas Department of State Health Services (TDSHS) (2013) Public health research uses of newborn screening blood spots: research uses that have been allowed by DSHS. Available at http://www.dshs.state.tx.us/lab/nbsBloodspotsUse.shtm. Accessed February 2014
Therrell B, Hannon H, Bailey D, Fleischman A, Goldman E, Monaco J, et al. (2009) Briefing paper: considerations and recommendations for a national policy regarding the retention and use of dried blood spot specimens after newborn screening. Available at http://resourcerepository.org/documents/1681/briefingpaper:considerationsandrecommendationsforanationalpolicyregardingtheretentionanduseofdriedbloodspotspecimensafternewborns/ Accessed January 2013
Therrell B, Hannon WH, Bailey DB, Goldman EB, Monaco J, Norgaard-Pedersen B et al (2011) Committee report: considerations and recommendations for national guidance regarding the retention and use of residual dried blood spot specimens after newborn screening. Genetics Med 13(7):621–624
United Kingdom Newborn Screening Programme Centre (2005) Code of practice for the retention and storage of residual spots: expert group. Available at http://newbornbloodspot.screening.nhs.uk/getdata.php?id=11102. Accessed September 2014
United Nations Educational, Scientific and Cultural Organization (2005) Universal Declaration on Bioethics and Human Rights
University of Michigan Health System (2011) Restoring trust vital in public acceptance of the use of residual newborn screening specimens. Science Daily. Available at http://www.uofmhealth.org/News/newborn-tarini-0613. November 2012
Willyard C (2012) Archived blood spots could be epigenetic jackpot. Nature. doi:10.1038/nature.2012.11258
Compliance with ethics guidelines
The manuscript complies with the Canadian research ethics guidelines as set out by the 2nd edition of Tri-Council Policy Statement. No human subjects were involved. Only publicly available documents were analyzed.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cunningham, S., O’Doherty, K.C., Sénécal, K. et al. Public concerns regarding the storage and secondary uses of residual newborn bloodspots: an analysis of print media, legal cases, and public engagement activities. J Community Genet 6, 117–128 (2015). https://doi.org/10.1007/s12687-014-0206-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12687-014-0206-0